Free Speech and Pharmaceutical Regulation -- Fishy Business

JAMA Intern Med. 2016 Mar;176(3):295-6. doi: 10.1001/jamainternmed.2015.8155.
No abstract available

MeSH terms

  • Cardiovascular Diseases / prevention & control
  • Direct-to-Consumer Advertising* / legislation & jurisprudence
  • Direct-to-Consumer Advertising* / trends
  • Drug Approval / legislation & jurisprudence*
  • Drug Industry / legislation & jurisprudence*
  • Drugs, Investigational* / therapeutic use
  • Eicosapentaenoic Acid / analogs & derivatives
  • Eicosapentaenoic Acid / therapeutic use
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Information Dissemination / legislation & jurisprudence*
  • Legislation as Topic*
  • Legislation, Drug / standards
  • Legislation, Drug / trends*
  • Off-Label Use* / legislation & jurisprudence
  • Secondary Prevention / methods
  • United States
  • United States Food and Drug Administration

Substances

  • Drugs, Investigational
  • Hypolipidemic Agents
  • eicosapentaenoic acid ethyl ester
  • Eicosapentaenoic Acid